Table 2.

Demographic and clinical data of patients included in the validation phase of the study.

Group	n	Gender (M/F)	Age	OSDI	TBUT	Schirmer I test	Fluorescein staining
CT	9	3/6	36.78 ± 20.41	2.39 ± 2.45	13.39 ± 5.97	18.06 ± 5.85	0.33 ± 0.50
DE	24	10/14	54.58 ± 21.55	35.92 ± 19.37	6.21 ± 3.51	5.58 ± 5.30	1.50 ± 1.25

CT = Control; DE = Dry eye.